RSS   Newsletter   Contact   Advertise with us
Post Online Media

Edge Therapeutics appoints Rosemary A. Crane to board

Rosemary A. CraneSeptember 20, 2017, Berkeley Heights, N.J., USA - Edge Therapeutics, a clinical-stage biotechnology company, announced the appointment of Rosemary A. Crane to Edge’s board of directors.
Ms. Crane currently serves as a Director of Teva Pharmaceuticals and as Vice Chairman of the Board of Zealand Pharma A/S.

Ms. Crane held senior executive positions at Johnson & Johnson, including Group Chairman, OTC & Nutritional Group, Group Chairman, Consumer, Specialty Pharmaceuticals and Nutritionals, and Executive Vice President of Global Marketing for the Pharmaceutical Group.

Ms. Crane has also served in executive roles at Bristol-Myers Squibb, including President of U.S. Primary Care and President of Global Marketing and Consumer Products.

She also served as President and Chief Executive Officer of MELA Sciences, Inc. and President and Chief Executive Officer of Epocrates, Inc.

Ms. Crane received her MBA from Kent State University and her BA in Communications and English from the State University of New York.




POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.